| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/21/2007 | EP1763369A1 Combinations comprising antimuscarinic agents and corticosteroids |
| 03/21/2007 | EP1763368A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1763358A1 Appetite-suppressing compositions and methods |
| 03/21/2007 | EP1763356A2 Composition comprising a survivin antisense oligonucleotide and gemcitabine for the treatment of cancer |
| 03/21/2007 | EP1763355A1 Use of composition comrising d-mannoheptulose and/or perseitol for the treatment and prevention of diseases linked to a modification of the innate immunity |
| 03/21/2007 | EP1763354A2 Use of reboxetine for the treatment of pain |
| 03/21/2007 | EP1763353A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR |
| 03/21/2007 | EP1763352A1 Combination product comprising src kinase inhibitor azd0530 and an antioestrogen or egfr-tk-inhibitor |
| 03/21/2007 | EP1763351A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1763350A1 Nicotinamide derivatives and their use as therapeutic agents |
| 03/21/2007 | EP1763349A2 Pharmaceutical compositions for the treatment of pruritus |
| 03/21/2007 | EP1763348A1 Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors |
| 03/21/2007 | EP1763347A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 03/21/2007 | EP1763346A2 Compositions and methods relating to pyrimidine synthesis inhibitors |
| 03/21/2007 | EP1763345A2 Kinase inhibitors for treating cancers |
| 03/21/2007 | EP1763344A1 Medicaments for inhalation comprising steroids and an anticholinergic |
| 03/21/2007 | EP1763343A2 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 03/21/2007 | EP1763342A2 Sphingolipids against pathological processes in lipid rafts |
| 03/21/2007 | EP1763341A2 Compositions and methods for treating pathological infections |
| 03/21/2007 | EP1763339A1 Oral antimicrobial pharmceutical compositions |
| 03/21/2007 | EP1763337A2 Immediate, controlled and sustained release formulations of galanthamine |
| 03/21/2007 | EP1763321A2 Systems and methods for improving image-guided tissue ablation |
| 03/21/2007 | EP1763317A1 Synthesis of porphyrins designed for attachment to electroactive surfaces via one or more carbon tethers |
| 03/21/2007 | EP1697394B1 Comt inhibitors |
| 03/21/2007 | EP1678189B1 Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(iv) salts and derivatives and their use for the preparation of pharmaceutical active agents |
| 03/21/2007 | EP1663141B1 Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline |
| 03/21/2007 | EP1651270B1 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 03/21/2007 | EP1633377B1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/21/2007 | EP1578740B1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
| 03/21/2007 | EP1569643A4 Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome |
| 03/21/2007 | EP1551409B1 Use of the quinazoline derivative zd6474 combined with gemcitabine and optionally ionising radiation in the treatment of cancer |
| 03/21/2007 | EP1539752B1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via novel imidazo[4,5-c]quinolin-4-cyano and 1h-imidazo[4,5-c]quinolin-4-carboxamide intermediates |
| 03/21/2007 | EP1515710B1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 03/21/2007 | EP1496864B1 Pharmaceutical composition containing lamotrigine particles of defined morphology |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1467711B1 Dna dosage forms |
| 03/21/2007 | EP1465607B1 Pharmaceutical formulations with modified release |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1455782B1 High-concentration stable meloxicam solutions for needle-less injection |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/21/2007 | EP1397127B1 Solid pharmaceutucal formulations comprising modafinil |
| 03/21/2007 | EP1385520A4 Methods and compounds for the treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| 03/21/2007 | EP1385492B1 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis |
| 03/21/2007 | EP1365787B1 Use of amino acid anticonvulsants for treatment of pain |
| 03/21/2007 | EP1361867B1 Fibrate-statin combinations with reduced fed-fasted effects |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | EP1339415B1 composition of multipurpose high functional alkaline solution composition, preparation thereof, and use as nonspecific immunostimulator |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1337261B1 Laminarin sulphate-based anti-inflammatory medicament |
| 03/21/2007 | EP1330460B1 Benzoxazinone derivatives, their preparation and use |
| 03/21/2007 | EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 03/21/2007 | EP1296663B1 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/21/2007 | EP1289529B1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 03/21/2007 | EP1248616B1 Functional coating of linezolid microcapsules for oral administration |
| 03/21/2007 | EP1242059B1 Novel prodrugs for antimicrobial amidines |
| 03/21/2007 | EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 03/21/2007 | EP1235899B1 Treatment of human infertility |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | EP1207872B1 Ibuprofen-containing softgels |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1133298B1 Compositions comprising cefuroxime axetil |
| 03/21/2007 | EP1112270B1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
| 03/21/2007 | EP1100513B1 Method for producing autoinducer synthase |
| 03/21/2007 | EP1003494B1 (d)-METHADONE, A NONOPIOID ANALGESIC |
| 03/21/2007 | EP0966532B1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 03/21/2007 | EP0954283B1 Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation |
| 03/21/2007 | EP0907724B1 Von willebrand factor multimerase |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | EP0886640B1 SIALYL-LEWISa AND SIALYL-LEWISx EPITOPE ANALOGUES |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | EP0805853B1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 03/21/2007 | CN2880078Y Composite capsules for treating gastroenteropathy |
| 03/21/2007 | CN1934299A Method for providing antimicrobial composite yarns, composite fabrics and articles made therefrom |
| 03/21/2007 | CN1934273A Treatment and determiming |
| 03/21/2007 | CN1934256A Decoy nucleic acid to synoviolin gene promoter |
| 03/21/2007 | CN1934255A Combination therapy for the treatment of ocular neovascular disorders |
| 03/21/2007 | CN1934251A Treatment of neurodegenerative diseases by the use of atp7a |
| 03/21/2007 | CN1934141A Orthoester-protected polyols for low VOC coatings |
| 03/21/2007 | CN1934125A 黄体酮受体调节剂 Progesterone receptor modulators |
| 03/21/2007 | CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934120A Novel inhibitors of chymase |
| 03/21/2007 | CN1934118A Trihemihydrate, anhydrate and hydrate forms of cefdinir |
| 03/21/2007 | CN1934117A Macrolides and methods for producing same |
| 03/21/2007 | CN1934116A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 03/21/2007 | CN1934113A Compositions useful as inhibitors of protein kinases |
| 03/21/2007 | CN1934112A Fused hetrocyclic compounds and their use as metabotropic receptor antagonists |
| 03/21/2007 | CN1934111A Heteroaryl-fused pyrazolo derivatives |
| 03/21/2007 | CN1934109A Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 03/21/2007 | CN1934108A Polymorphic form B2 of ziprasidone base |
| 03/21/2007 | CN1934107A 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors |
| 03/21/2007 | CN1934106A New process for the preparation of diazine derivatives |
| 03/21/2007 | CN1934105A Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| 03/21/2007 | CN1934104A Compounds for the treatment of diseases |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |